United States Ex Rel. Public Integrity v. Therapeutic Technology Inc.

895 F. Supp. 294, 1995 U.S. Dist. LEXIS 15154, 1995 WL 480594
CourtDistrict Court, S.D. Alabama
DecidedAugust 7, 1995
Docket93-0138-RV-M
StatusPublished
Cited by6 cases

This text of 895 F. Supp. 294 (United States Ex Rel. Public Integrity v. Therapeutic Technology Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States Ex Rel. Public Integrity v. Therapeutic Technology Inc., 895 F. Supp. 294, 1995 U.S. Dist. LEXIS 15154, 1995 WL 480594 (S.D. Ala. 1995).

Opinion

ORDER

VOLLMER, District Judge.

I. This matter is before the Court on the third-party plaintiffs “motion for leave to file corrected oppositions” (tab 56).

*295 II. This matter is also before the Court on the “plaintiffs motion to dismiss, or in the alternative, for separate trials of defendants’ third party claims” (tab 51) and the “motion of HNE Healthcare, Inc. to strike or, in the alternative, to dismiss the third-party complaint” (tabs 49, 50). The third-party plaintiffs submitted an opposition (tab 56) to the motions. HNE Healthcare submitted a reply (tab 65) to the opposition, and similarly the government submitted a rebuttal response (tab 67) to the opposition.

III. This matter is also before the Court on the “motion of HNE Healthcare, Inc. for a separate trial and a stay of discovery” (tabs 47, 48).

IV. In addition, this matter is before the Court on the “defendants’ motion to dismiss complaint” (tab 55). The government submitted a response (tab 63) to the defendants’ motion.

V. Finally, this matter is before the Court on the government’s “motion for order allowing the filing and serving of an amended complaint” (tab 57). The defendants submitted an opposition (tab 64) to the government’s motion. The government then submitted a response (tab 68) to that opposition.

BACKGROUND

1. This litigation began with a qui tam suit filed by Public Integrity in the name of the United States, filed on February 24, 1993. The action arose under 31 U.S.C. § 3729 et seq., known as the “False Claims Act” (FCA).

2. Defendant Therapeutic Technology Inc. (TTI) is a provider of medical equipment in this district. Charles W. Moody was at all relevant times President and part owner of TTI. In the past, TTI received payments from the United States under the Medicare and Medicaid programs for the provision of medical equipment. The complaint alleges that TTI made claims for Lymphedema pumps and related equipment which were not qualified for coverage under Medicare or Medicaid rules or regulations and were not medically necessary. The complaint alleges that TTI knew that the claims for reimbursement were improper, and that those claims were false and/or fraudulent under 31 U.S.C. § 3729.

3. The complaint remained under seal pursuant to 31 U.S.C. § 3730 while the government investigated the allegations. On May 16,1994, following the investigation, the government elected to intervene and assumed primary responsibility for prosecuting the action. The original complaint and the notice of intervention were unsealed (tab 17) at that time. On November 9, 1994, the United States filed an amended complaint (tab 19) in this action. The government’s amended complaint alleged that the defendant created false records and submitted false information to obtain payments under the Medicare program to which they were not entitled.

4. After filing their original answers (tabs 28, 29) in December, 1994, TTI and Moody filed a third-party complaint (tab 36) against HNE Healthcare, Inc. (HNE) on March 9, 1995. HNE was the manufacturer of the Lymphedema pumps at issue is this suit. The third-party claims are based solely on state law causes of action based on breach of contract, breach of warranty, and fraud. In substance, TTI and Moody allege that HNE should indemnify them for any damages that they are required to pay for the government’s claims under the FCA.

DISCUSSION

I. Motion for Leave to File Corrected Oppositions

Regarding the third-party plaintiffs “motion for leave to file corrected oppositions” (tab 56), they seek leave to file a new opposition with certain grammatical and typographical corrections, but with no substantive changes. The third-party plaintiffs “motion for leave to file corrected oppositions” (tab 56) is hereby GRANTED.

II. Dispositive Motions regarding Third-Party Claims

1. Regarding the “plaintiffs motion to dismiss, or in the alternative, for separate trials of defendants’ third party claims” (tab 51) and the “motion of HNE Healthcare, Inc. to strike or, in the alternative, to dismiss the *296 third-party complaint” (tabs 49, 50), the court will consider these motions together. The third-party plaintiffs submitted an opposition (tab 56) to the motions. HNE Healthcare submitted a reply (tab 65) to the opposition, and similarly the government filed a rebuttal response (tab 67) to the opposition.

2. In their briefs, the government and HNE each specify various reasons that the third-party complaint should be dismissed. The Court will presently focus on the government’s primary argument in its motion to dismiss (tab 51), which provides that the Court should dismiss the third-party claim pursuant to 28 U.S.C. 1367. The third-party plaintiffs filed their complaint pleading jurisdiction under 28 U.S.C. § 1867(a). This statute defines the Court’s supplemental jurisdiction, giving Courts jurisdiction to hear state claims against third parties if the state claims are so related to the original claims “that they form part of the same case and controversy.”

3. The decision of whether to accept or reject jurisdiction is vested in the courts, as “the district court may decline to exercise supplemental jurisdiction ... if ... there are other compelling reasons for declining jurisdiction.” 28 U.S.C. 1367(c). In making the determination, the Court must strongly consider “judicial economy, convenience, and fairness to the litigants.” United Mine Workers v. Gibbs, 383 U.S. 715, 726, 86 S.Ct. 1130, 1139, 16 L.Ed.2d 218 (1966). In the present case, the factors which would warrant the Court’s exercise of supplemental jurisdiction are not present. The third-party claims are due to be dismissed for the reasons that follow.

4. In other FCA eases, courts have not allowed third-party claims for indemnification. See United States ex rel. Stephens v. Prabhu, 1994 WL 761237 (D.Nev.1994). These Courts have held that FCA defendants are precluded as a matter of law from seeking indemnification from a third-party defendant, and that such claims must be dismissed. U.S. v. Nardone, 782 F.Supp. 996, 999 (M.D.Pa.1990); U.S. v. Entin, S.D.Fla. CV 84-2422 (Order, Scott, J., March 4, 1986); U.S. v. Kennedy, 431 F.Supp. 877, 878 (C.D.Cal.1977). Also note that in Israel Discount Bank Ltd. v. Entin,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

US Ex Rel. Miller v. BILL HARBERT INTERN. CONST.
505 F. Supp. 2d 20 (District of Columbia, 2007)
United States v. AIT Worldwide Logistics, Inc.
441 F. Supp. 2d 762 (E.D. Virginia, 2006)
United States v. Dynamics Research Corp.
441 F. Supp. 2d 259 (D. Massachusetts, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
895 F. Supp. 294, 1995 U.S. Dist. LEXIS 15154, 1995 WL 480594, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-ex-rel-public-integrity-v-therapeutic-technology-inc-alsd-1995.